News

Under the license agreement, Medivation will be responsible for all development, regulatory and commercialization activities for pidilizumab for all indications, including oncology. The agreement includes a guaranty with

Under the terms of agreement, Ariad will lead the completion of the Japanese new drug application (NDA) for Iclusig, while Otsuka will file the NDA for regulatory approval

The grant award will assist with advancing an SVP cancer immunotherapy from preclinical through early clinical evaluation. This immuno-oncology program is designed to develop novel SVP immunotherapies capable

With the approval of this additional administration option, physicians will soon have the flexibility to prescribe GRANIX for either in-office or at home use. GRANIX, a leukocyte growth

Undertaken at the US Army Medical Research Institute of Infectious Diseases (USAMRIID), the proof-of-concept study was focused on assessing the effect of BCX4430 treatment on survival through day

Rosacea is a common, but often misunderstood, skin disorder affecting 16 million Americans,predominantly women, ages 30 and older. Although the cause of rosacea is unknown, research suggests that

By using real-world evidence, the two parties will focus on developing answers to commonly asked clinical questions about the continuum of diabetes care, such as the role and

The approval was based by data from over 2,700 subjects treated with peramivir in 27 clinical trials. University of Alabama Dr Richard Whitley said: "RAPIVAB is the first

Opdivo is a human programed death receptor-1 (PD-1) blocking antibody indicated to treat this skin cancer. The indication is approved under accelerated approval based on tumor response rate